These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29541430)

  • 41. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
    Gupta BK; Saha AK; Mukherjee S; Saha B
    Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cromolyn sodium for the prevention of chronic lung disease in preterm infants.
    Ng GY; Ohlsson A
    Cochrane Database Syst Rev; 2001; (2):CD003059. PubMed ID: 11406065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
    Lemyre B; Deguise MO; Benson P; Kirpalani H; Ekhaguere OA; Davis PG
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD005384. PubMed ID: 37466143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Three Different Administration Positions for Intratracheal Beractant in Preterm Newborns with Respiratory Distress Syndrome.
    Karadag A; Ozdemir R; Degirmencioglu H; Uras N; Dilmen U; Bilgili G; Erdeve O; Cakir U; Atasay B
    Pediatr Neonatol; 2016 Apr; 57(2):105-12. PubMed ID: 26190853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.
    Ng GY; da S; Ohlsson A
    Cochrane Database Syst Rev; 2001; (3):CD003214. PubMed ID: 11687053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation.
    Silver RK; Vyskocil C; Solomon SL; Ragin A; Neerhof MG; Farrell EE
    Obstet Gynecol; 1996 May; 87(5 Pt 1):683-91. PubMed ID: 8677067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic lung disease of the very low birth weight infant--is it preventable?
    Ogawa Y
    Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China.
    Han T; Liu H; Zhang H; Guo M; Zhang X; Duan Y; Sun F; Liu X; Zhang X; Zhang M; Liu F; Bao L; Xiao M; Liu W; Jiang R; Zheng J; Tian X; Gao Q; Zhang W; Guo W; Li L; Tong X
    Front Pediatr; 2020; 8():182. PubMed ID: 32457854
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2012 May; (5):CD002058. PubMed ID: 22592683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Sustained Lung Inflation, a lung recruitment maneuver in primary acute respiratory distress syndrome, in respiratory and cerebral outcomes in preterm infants.
    Grasso C; Sciacca P; Giacchi V; Carpinato C; Mattia C; Palano GM; Betta P
    Early Hum Dev; 2015 Jan; 91(1):71-5. PubMed ID: 25549915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial.
    Kribs A; Roll C; Göpel W; Wieg C; Groneck P; Laux R; Teig N; Hoehn T; Böhm W; Welzing L; Vochem M; Hoppenz M; Bührer C; Mehler K; Stützer H; Franklin J; Stöhr A; Herting E; Roth B;
    JAMA Pediatr; 2015 Aug; 169(8):723-30. PubMed ID: 26053341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
    Halliday HL; Patterson CC; Halahakoon CW;
    Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus.
    Sadeck LS; Leone CR; Procianoy RS; Guinsburg R; Marba ST; Martinez FE; Rugolo LM; Moreira ME; Fiori RM; Ferrari LL; Menezes JA; Venzon PS; Abdallah VQ; Duarte JL; Nunes MV; Anchieta LM; Alves Filho N
    J Pediatr (Rio J); 2014; 90(6):616-23. PubMed ID: 25046256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H; Xu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
    J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.